Wnt signaling, Ca2+, and cyclic GMP: visualizing Frizzled functions

Hsien-Yu Wang1, Craig C Malbon

  • 1Department of Physiology and Biophysics, Health Sciences Center, State University of New York at Stony Brook, Stony Brook, NY 11794-8661, USA.

Science (New York, N.Y.)
|June 7, 2003
PubMed

Insights

Wnt proteins regulate cell development through various pathways, including beta-catenin signaling and influencing intracellular calcium and cGMP levels. These signaling cascades involve G proteins and RGS proteins, linking Wnt functions to visual pathway elements.

Area of Science:

  • Cell Biology
  • Developmental Biology
  • Molecular Signaling

Background:

  • Wnt proteins are crucial signaling molecules that regulate fundamental cellular processes such as cell fate specification, adhesion, migration, polarity, and proliferation.
  • Their diverse roles in embryonic development have been extensively studied across various model organisms, including fruit flies, nematodes, zebrafish, frogs, and mice.
  • Wnt signaling pathways are complex, with some pathways modulating beta-catenin degradation to control gene transcription, while others operate through distinct mechanisms.

Purpose of the Study:

  • To elucidate the multifaceted mechanisms of Wnt signaling beyond the canonical beta-catenin pathway.
  • To investigate the involvement of G proteins and RGS proteins in non-canonical Wnt signaling.
  • To explore the connection between Wnt-mediated regulation of intracellular calcium and cGMP and known signaling pathways.

Main Methods:

  • The study likely involved molecular biology techniques to probe Wnt signaling pathways.
  • Investigated the role of beta-catenin in Wnt-mediated gene regulation.
  • Examined the impact of Wnt signaling on intracellular Ca2+ and cyclic guanosine monophosphate (cGMP) concentrations.
  • Assessed the involvement of heterotrimeric guanine nucleotide-binding proteins (G proteins) and RGS proteins in these processes.

Main Results:

  • Identified distinct Wnt signaling pathways, including those that regulate beta-catenin and those that modulate intracellular Ca2+ and cGMP levels.
  • Demonstrated that Wnt regulation of Ca2+ and cGMP requires specific components of the visual signaling pathway, namely the G protein transducin and a cGMP-specific phosphodiesterase.
  • Highlighted the involvement of G proteins and RGS proteins in mediating Wnt signal transduction.

Conclusions:

  • Wnt signaling encompasses diverse pathways, including canonical beta-catenin-dependent and non-canonical pathways affecting ion concentrations.
  • Specific components of the visual signaling pathway, such as transducin and cGMP-specific phosphodiesterase, are essential for certain Wnt-mediated cellular responses.
  • This research expands the understanding of Wnt signaling complexity and its integration with other cellular processes.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...